Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Other Equity Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Other Equity
-$385k
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
7%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Other Equity
-CA$33.7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Other Equity
$860k
CAGR 3-Years
-40%
CAGR 5-Years
-28%
CAGR 10-Years
24%
Repare Therapeutics Inc
NASDAQ:RPTX
Other Equity
$28k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Other Equity
CA$3.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
31%
Spectral Medical Inc
TSX:EDT
Other Equity
CA$11.3m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is Aurinia Pharmaceuticals Inc's Other Equity?
Other Equity
-385k USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Other Equity amounts to -385k USD.

What is Aurinia Pharmaceuticals Inc's Other Equity growth rate?
Other Equity CAGR 10Y
7%

Over the last year, the Other Equity growth was 57%. The average annual Other Equity growth rates for Aurinia Pharmaceuticals Inc have been 22% over the past three years , 14% over the past five years , and 7% over the past ten years .

Back to Top